Guanfacine Tablet, Extended Release
Product Images NDC 60429-960

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 60429-960). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

60429 960 01ol

60429 960 01ol
This is a description for Guanfacine, an extended-release tablet produced by GSMS Incorporated that contains 1.14mg of guanfacine hydrochloride equivalent to 1mg guanfacine. The tablets come in a package of 100 and should be stored in a container that is tight and light-resistant. The tablets should not be chewed, crushed, or broken before swallowing. The medication should be kept out of reach of children. Information about the dosage can be found in the package insert. The manufacturer is TWi Pharmaceuticals, Inc, and the tablets are packaged by GSMS Incorporated in Camarillo, CA.*
FDA Label Image

60429 961 01

60429 961 01
This is a description for Guanfacine, an extended-release tablet manufactured by TWi Pharmaceuticals, Inc. and packaged by GSMS, Incorporated. It contains 2mg of guanfacine hydrochloride, which should not be crushed, chewed, or broken before swallowing. The tablets come in a package of 100 and should be stored at 20° to 25°C (88° to 77°F). For dosage instructions, see the package insert. The label also contains the NDC number, dosage strength, and warnings about keeping the medication out of the reach of children and dispensing in a tight, light-resistant container.*
FDA Label Image

60429 962 01ol

60429 962 01ol
This is a description of Guanfacine extended-release tablets manufactured by TW1 Pharmaceuticals, Inc. and packaged by GSMS, Inc. The tablets contain 3 mg guanfacine hydrochloride and are not to be crushed, chewed, or broken before swallowing. The medication should be dispensed in a tight, light-resistant container and kept out of the reach of children. The package insert should be consulted for dosage instructions.*
FDA Label Image

60429 963 01ol

60429 963 01ol
This is a description for Guanfacine extended-release tablets, manufactured by TWI Pharmaceuticals, Inc. and packaged by GSMS Incorporated. The tablets come in a bottle of 100 and are not safe for children. The package insert should be consulted for dosage information, and the tablets should not be crushed, chewed, or broken before swallowing. The pharmacist should dispense this medicine with an attached patient information leaflet in a tight, light-resistant container. The tablets contain 4.56 mg of guanfacine hydrochloride equivalent to 4 mg guanfacine. It is recommended to store at 20-25°C.*
FDA Label Image

Figure-1.jpg (Figure 1)

Figure-1.jpg (Figure 1)
FDA Label Image

Figure-2.jpg (Figure 2)

Figure-2.jpg (Figure 2)
FDA Label Image

Figure-3.jpg (Figure 3)

Figure-3.jpg (Figure 3)
FDA Label Image

Figure-4.jpg (Figure 4)

Figure-4.jpg (Figure 4)
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
FDA Label Image

Molecular-structure.jpg (Molecular Structure)

Molecular-structure.jpg (Molecular Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.